Showing results (121-130 of 583) with videos related to
Sort By:
Pageof 59
Hematology/Oncology Clinics of North America|October 1, 1992
Treatment of venous thromboembolism with low molecular weight heparinsR D Hull, G F PineoSeminars in Thrombosis and Hemostasis|September 30, 2000
Low-molecular-weight heparin in the treatment of venous thromboembolismR D Hull, G F PineoJournal of Chemical Ecology|July 27, 2001
Olfaction in the Queensland fruit fly, Bactrocera tryoni. I: Identification of olfactory receptor neuron types responding to environmental odorsC D Hull, B W CribbBailliere'S Clinical Haematology|May 20, 1999
Heparin and low-molecular-weight heparin in the treatment of venous thromboembolismG F Pineo, R D HullHematology/Oncology Clinics of North America|January 11, 2005
Vitamin K antagonists and direct thrombin inhibitors: present and futureGraham F Pineo, Russell D HullEuropean Journal of Medical Research|June 24, 2004
Dalteparin: pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseasesGraham F Pineo, Russell D HullSeminars in Thrombosis and Hemostasis|January 1, 1994
Therapeutic use of low molecular weight heparins: knowledge to date and their application to therapyR D Hull, G F PineoChest|September 1, 1994
Relative risks of anticoagulant treatment of acute pulmonary embolism based on an angiographic diagnosis vs a ventilation/perfusion scan diagnosisP D Stein, R D HullClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 13, 2009
Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patientsGraham F Pineo, Russell D HullPopulation Health Management|February 15, 2013
Factors associated with participation in and benefits of a worksite wellness programRay M Merrill, John D HullPageof 59